How does Gaucher disease affect the liver?
Gaucher (go-SHAY) disease is the result of a buildup of certain fatty substances in certain organs, particularly your spleen and liver. This causes these organs to enlarge and can affect their function. The fatty substances also can build up in bone tissue, weakening the bone and increasing the risk of fractures.
What tests are used to diagnose Gaucher disease?
An enzyme test called a beta-glucosidase leukocyte (BGL) test is the main tool that physicians use to diagnose Gaucher disease. This is because all patients with Gaucher disease will have low enzyme activity levels. Your physician can measure enzyme activity with a standard blood test.
Why does Gaucher have spleen and liver?
When you have Gaucher disease, you are missing an enzyme that breaks down certain types of fatty substances (lipids). These lipids can build up in organs such as your spleen and liver. This condition can cause many different symptoms. Your spleen and liver may get very large and stop working normally.
What is the life expectancy of a person with Gaucher disease?
Many people with Gaucher disease have few symptoms and can expect a normal lifespan even without treatment. One study estimated life expectancy at birth for people with type 1 Gaucher disease to be 68 years, compared with 77 years in the general population.
What happens if Gaucher disease is left untreated?
Left untreated, Gaucher disease can cause severe arthritis and joint destruction. Parkinson disease: Carriers and patients with Gaucher disease have a slightly increased risk of developing Parkinson disease later in life.
Who is most likely to get Gaucher disease?
Anyone can have the disorder, but people with Ashkenazi Jewish (Eastern European) ancestry are more likely to have Gaucher disease type 1. Of all people of Ashkenazi (or Ashkenazic) Jewish descent, nearly 1 in 450 has the disorder, and 1 in 10 carries the gene change that causes Gaucher disease.
What age is Gaucher disease diagnosed?
In cases of Gaucher disease Type 1, data from the ICGG Gaucher Registry indicated that overall mean age at disease onset (defined as age at onset, at diagnosis, or at recognition) for patients was 20.4 years.
How do you know if you have Gaucher disease?
Major signs and symptoms include enlargement of the liver and spleen (hepatosplenomegaly), a low number of red blood cells (anemia ), easy bruising caused by a decrease in blood platelets (thrombocytopenia), lung disease, and bone abnormalities such as bone pain, fractures, and arthritis.
At what age is Gaucher disease diagnosed?
Individuals with Gaucher disease type 1 usually exhibit symptoms during adolescence, but the age of onset ranges from childhood to adulthood. The age of onset for Gaucher disease type 2 is during early infancy.
Which type of Gaucher disease is the most lethal?
The most severe type of Gaucher disease is called the perinatal lethal form. This condition causes severe or life-threatening complications starting before birth or in infancy.
What triggers Gaucher disease?
What causes Gaucher disease? Gaucher disease is passed down from parents to children (is inherited). It is caused by a problem with the GBA gene. It is an autosomal recessive disorder. This means that each parent must pass along an abnormal GBA gene for their child to get Gaucher.
Does Gaucher disease cause weight gain?
Diet as part of overall care for Gaucher disease
People with GD may be at higher risk for certain medical issues, and a nutritious diet can keep them on a healthy path. Weight gain: People often gain weight after starting ERT, which can lead to an increase in fatty liver and a risk of developing fatty liver disease.
When should you suspect Gaucher disease?
A diagnosis of Gaucher disease is suspected in individuals who have bone problems, enlarged liver and spleen (hepatosplenomegaly), changes in red blood cell levels, easy bleeding and bruising from low platlets or signs of nervous system problems.
Is Gaucher disease autoimmune?
Conclusions: Forty five percent of the evaluated type I Gaucher patients exhibited autoimmune phenomena.